Berenberg Bank Reiterates Buy Rating for ANGLE (LON:AGL)

Berenberg Bank reissued their buy rating on shares of ANGLE (LON:AGL) in a report published on Wednesday, MarketBeat.com reports. The firm currently has a GBX 70 ($0.86) target price on the stock.

ANGLE Stock Up 3.6 %

AGL stock opened at GBX 14.50 ($0.18) on Wednesday. The company has a market cap of £37.78 million, a price-to-earnings ratio of -161.11 and a beta of 0.20. The company has a debt-to-equity ratio of 14.26, a current ratio of 7.51 and a quick ratio of 6.18. ANGLE has a 12 month low of GBX 9.07 ($0.11) and a 12 month high of GBX 37.40 ($0.46). The company has a fifty day moving average price of GBX 14.32 and a 200 day moving average price of GBX 14.05.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.